These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 38926937)
1. Recompensation of cirrhosis in candidates of transplant: Tips and tricks for delisting. Tonon M; Gagliardi R; Zeni N; Piano S Liver Transpl; 2024 Nov; 30(11):1181-1187. PubMed ID: 38926937 [TBL] [Abstract][Full Text] [Related]
2. A notable proportion of liver transplant candidates with alcohol-related cirrhosis can be delisted because of clinical improvement. Pose E; Torrents A; Reverter E; Perez-Campuzano V; Campos-Varela I; Avitabile E; Gratacós-Ginès J; Castellote J; Castells L; Colmenero J; Tort J; Ginès P; Crespo G J Hepatol; 2021 Aug; 75(2):275-283. PubMed ID: 33746085 [TBL] [Abstract][Full Text] [Related]
3. Characteristics of liver transplant candidates delisted following recompensation and predictors of such delisting in alcohol-related liver disease: a case-control study. Aravinthan AD; Barbas AS; Doyle AC; Tazari M; Sapisochin G; Cattral MS; Ghanekar A; McGilvray ID; Selzner M; Greig PD; Bhat M; Selzner N; Grant DR; Lilly LB; Renner EL Transpl Int; 2017 Nov; 30(11):1140-1149. PubMed ID: 28686307 [TBL] [Abstract][Full Text] [Related]
4. Natural history of NASH cirrhosis in liver transplant waitlist registrants. Lim WH; Ng CH; Tan D; Tseng M; Xiao J; Yong JN; Zeng RW; Cho E; Tay P; Ang CZ; Koh JH; Teng M; Syn N; Kow A; Huang DQ; Tan EX; Rinella ME; Sanyal A; Muthiah M; Siddiqui MS J Hepatol; 2023 Oct; 79(4):1015-1024. PubMed ID: 37307997 [TBL] [Abstract][Full Text] [Related]
5. High risk of delisting or death in liver transplant candidates following infections: Results from the North American Consortium for the Study of End-Stage Liver Disease. Reddy KR; O'Leary JG; Kamath PS; Fallon MB; Biggins SW; Wong F; Patton HM; Garcia-Tsao G; Subramanian RM; Thacker LR; Bajaj JS; Liver Transpl; 2015 Jul; 21(7):881-8. PubMed ID: 25845966 [TBL] [Abstract][Full Text] [Related]
6. Validation of Baveno VII criteria for recompensation in entecavir-treated patients with hepatitis B-related decompensated cirrhosis. Wang Q; Zhao H; Deng Y; Zheng H; Xiang H; Nan Y; Hu J; Meng Q; Xu X; Fang J; Xu J; Wang X; You H; Pan CQ; Xie W; Jia J J Hepatol; 2022 Dec; 77(6):1564-1572. PubMed ID: 36038017 [TBL] [Abstract][Full Text] [Related]
7. Model for end-stage liver disease-sodium underestimates 90-day mortality risk in patients with acute-on-chronic liver failure. Hernaez R; Liu Y; Kramer JR; Rana A; El-Serag HB; Kanwal F J Hepatol; 2020 Dec; 73(6):1425-1433. PubMed ID: 32531416 [TBL] [Abstract][Full Text] [Related]
12. Baveno VII criteria for recompensation predict transplant-free survival in patients with hepatitis B-related decompensated cirrhosis. Hui VW; Wong GL; Wong VW; Chan HL; Lai JC; Tse YK; Lai MS; Yam TF; Li D; Fan X; Yip TC JHEP Rep; 2023 Sep; 5(9):100814. PubMed ID: 37546279 [TBL] [Abstract][Full Text] [Related]
13. A model including sarcopenia surpasses the MELD score in predicting waiting list mortality in cirrhotic liver transplant candidates: A competing risk analysis in a national cohort. van Vugt JLA; Alferink LJM; Buettner S; Gaspersz MP; Bot D; Darwish Murad S; Feshtali S; van Ooijen PMA; Polak WG; Porte RJ; van Hoek B; van den Berg AP; Metselaar HJ; IJzermans JNM J Hepatol; 2018 Apr; 68(4):707-714. PubMed ID: 29221886 [TBL] [Abstract][Full Text] [Related]
14. Management of liver transplantation waiting list for decompensated cirrhosis in a Spanish tertiary hospital: differences between hepatitis C virus recipients and other etiologies. Ibáñez Samaniego L; Pérez Valderas M; Fernández Yunquera A; Rincón Rodríguez D; López Baena JA; Matilla Peña A; Catalina Rodríguez MV; Clemente Ricote G; Bañares Cañizares R; Salcedo Plaza M Transplant Proc; 2014 Nov; 46(9):3084-6. PubMed ID: 25420829 [TBL] [Abstract][Full Text] [Related]
15. Disability in patients with end-stage liver disease: Results from the functional assessment in liver transplantation study. Samoylova ML; Covinsky KE; Haftek M; Kuo S; Roberts JP; Lai JC Liver Transpl; 2017 Mar; 23(3):292-298. PubMed ID: 27884053 [TBL] [Abstract][Full Text] [Related]
16. The Baveno VII concept of cirrhosis recompensation. Reiberger T; Hofer BS Dig Liver Dis; 2023 Apr; 55(4):431-441. PubMed ID: 36646527 [TBL] [Abstract][Full Text] [Related]
17. A new prognostic model to predict dropout from the waiting list in cirrhotic candidates for liver transplantation with MELD score <18. Biselli M; Dall'Agata M; Gramenzi A; Gitto S; Liberati C; Brodosi L; Ravaioli M; Gambato M; Montalti R; Pinna AD; Burra P; Gerunda GE; Cillo U; Andreone P; Bernardi M Liver Int; 2015 Jan; 35(1):184-91. PubMed ID: 24650058 [TBL] [Abstract][Full Text] [Related]
18. Waiting list mortality of patients with primary biliary cirrhosis in the Japanese transplant allocation system. Genda T; Ichida T; Sakisaka S; Sata M; Tanaka E; Inui A; Egawa H; Umeshita K; Furukawa H; Kawasaki S; Inomata Y J Gastroenterol; 2014 Feb; 49(2):324-31. PubMed ID: 23478939 [TBL] [Abstract][Full Text] [Related]
19. Impact of acute kidney injury response on survival and liver transplant rates in hospitalized patients with cirrhosis awaiting liver transplantation: Results from the HRS-HARMONY consortium. Li X; Ouyang T; Belcher JM; Patidar KR; Cullaro G; Asrani SK; Wadei HM; Simonetto DA; Regner KR; Dageforde LA; Przybyszewski EM; Wilechansky RM; Sharma P; Ufere NN; Duarte-Rojo A; Wahid NA; Orman ES; St Hillien SA; Robinson JE; Chung RT; Allegretti AS; Liver Transpl; 2024 Nov; 30(11):1106-1115. PubMed ID: 39073567 [TBL] [Abstract][Full Text] [Related]
20. Recompensation after TIPS reduces the incidence of hepatocellular carcinoma and increases survival in patients with cirrhosis. Sánchez J; González S; Poyatos P; Escudero MD; Montón C; Carbonell JA; Casula E; Guijarro J; Lluch P; Ballester MP Liver Int; 2024 Nov; 44(11):3072-3082. PubMed ID: 39221765 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]